Mechanisms of myocardial protection by adenosine-supplemented cardioplegia: Differential response of calcium-independent protein kinase C isozymes

Journal of Surgical Research

Volumn 89, Issue 2, 2000, Pages 163-168

  Nawas, Sammy I ^a   Schwertz, Dorie W ^a   Beck, Jennifer M ^a   Fogelson, Bernard G ^a   Law, William R ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Cardiac arrest; Cardiac surgery; Isozymes; Myocardial function; Protein kinase C

Indexed keywords

ADENOSINE; CALCIUM; CARDIOPLEGIC AGENT; ISOENZYME; PROTEIN KINASE C; ST THOMAS HOSPITAL SOLUTION;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME POLYMORPHISM; HEART ARREST; HEART PERFUSION; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034030853     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2000.5824     Document Type: Article

References (28)

1. Hudspeth D. A., Nakanishi K., Vinten-Johansen J., Zhou Z., McGee S., Williams M. W., Hammon J. W. Adenosine in blood cardioplegia prevents postischemic dysfunction in ischemically injured hearts. Ann. Thorac. Surg. 58:1994;1637.
2. Schubert T., Vetter H., Owen P., Reichart B., Opie L. H. Adenosine cardioplegia. J. Thorac. Cardiovasc. Surg. 98:1989;1057.
3. de Jong J. W., van de Meer P., van Loon H., Owen P., Opie L. H. Adenosine as adjunct to potassium cardioplegia: Effect on function, energy metabolism, and electrophysiology. J. Thorac. Cardiovasc. Surg. 100:1990;445.
4. Wyatt D. A., Ely S. W., Lasley R. D., Walsh R., Mainwaring R., Berne R. M., Mentzer R. M. Purine-enriched asanguinous cardioplegia retards adenosine triphosphate degradation during ischemia and improves postischemic ventricular function. J. Thorac. Cardiovasc. Surg. 97:1989;771.
5. Bolling S. F., Bies L. E., Gallagher K. P., Bove E. L. Enhanced myocardial protection with adenosine. Ann. Thorac. Surg. 47:1989;809.
6. Fogelson B. G., Nawas S. I., Law W. R. Mechanisms of myocardial protection in adenosine-supplemented cardioplegia: Myofilament and metabolic responses. J. Thorac. Cardiovasc. Surg. 1999.
7. Lasley R. D., Mentzer R. M. Jr. Protective effects of adenosine in the reversibly injured heart. Ann. Thorac. Surg. 60:1995;843.
8. 1 receptor activation in the rabbit. J. Cardiovasc. Pharmacol. 29:1997;631.
9. Downey J. M., Cohen M. V., Ytrehus K., Liu Y. Cellular mechanisms in ischemic preconditioning: The role of adenosine and protein kinase C. Ann. N.Y. Acad. Sci. 723:1994;82.
10. Rohs T. J., Kilgore K. S., Georges A. J., Bolling S. F. Postischemic function and protein kinase C signal transduction. Ann. Thorac. Surg. 65:1999;1680.
11. Bogoyevitch M. A., Parker P. J., Sugden P. H. Characterization of protein kinase C isotype expression in adult rat heart. Circ. Res. 72:1993;757.
12. Steinberg S. F., Goldberg M., Rybin V. O. Protein kinase C isoform diversity in the heart. J. Mol. Cell. Cardiol. 27:1995;141.
13. Weiss J. L., Frederiksen J. W., Weisfeldt M. L. Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J. Clin. Invest. 58:1976;751.
14. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680.
15. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350.
16. Ytrehus K., Liu Y., Downey J. M. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am. J. Physiol. 266:1994;H1145.
17. Meldrum D., Cleveland J., Meng X., Sheridan B., Gamboni F., Cain B., Harken A., Barnard M. L. Protein kinase C isoform diversity in preconditioning. J. Surg. Res. 69:1997;183.
18. Speechly-Dick M. E., Mocanu M. M., Yellon D. M. Protein kinase C: Its role in ischemic preconditioning in the rat. Circ. Res. 75:1994;586.
19. Ikonomidis J., Shirai T., Weisel R., Derylo B., Rao V., Whiteside C., Mickle D., Li R. Preconditioning cultured human pediatric myocytes requires adenosine and protein kinase C. Am. J. Physiol. 272:1997;H1220.
20. Ping P., Zhang J., Qui Y., Tang X., Manchikalapudi S., Cao X., Bolli R. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and nu in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ. Res. 81:1998;404.
21. 1 receptor stimulation antagonizes the negative inotropic effects of the PKC activator dioctoanoylglycerol. J. Mol. Cell. Cardiol. 30:1998;913.
22. Nissinen J., Raatikainen P., Karlqvist K., Peuhkurinen K. Efflux of adenosine and its catabolites during cold blood cardioplegia. Ann. Thorac. Surg. 55:1993;1546.
23. Clement O., Pucéat M., Walsh M. P., Vassort G. Protein kinase C enhances myosin light-chain kinase effects on force development and ATPase activity in single skinned cardiac cells. Biochem. J. 285:1992;311.
24. Powers F. M., Fogelson B. G., Sturgeon C., Solaro R. J., Law W. R. Depressed myofilament cooperativity associated with post-cardioplegic myocardial depression. J. Mol. Cell. Cardiol. 30:1998;1779.
25. 2+ transport. Circ. Res. 77:1995;88.
26. Fang H. K., Sturgeon C., Segil L. J., Ripper R. L., Law W. R. Cardiac contractile function during coronary stenosis in dogs: Association of adenosine in glycolytic dependence. Am. J. Physiol. 272:1997;H2195.
27. Biethinger M., Hoffmann R., Hofer H. W. Phosphofructokinase from mollusc muscle is activated by phosphorylation. Arch. Biochem. Biophys. 287:1991;263.
28. Depre C., Ponchaut S., Deprez J., Maisin L., Hue L. Cyclic AMP suppresses the inhibition of glycolysis by alternative oxidizable substrates in the heart. J. Clin. Invest. 101:1998;390.